SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-021772
Filing Date
2021-11-04
Accepted
2021-11-04 16:12:06
Documents
16
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K advm-20211104.htm   iXBRL 8-K 33048
2 EX-99.1 exhibit991_110421pressrele.htm EX-99.1 22594
6 GRAPHIC advm_bsa.jpg GRAPHIC 1314836
7 GRAPHIC advm_soa.jpg GRAPHIC 836815
8 GRAPHIC logoa.jpg GRAPHIC 9327
  Complete submission text file 0001628280-21-021772.txt   3171925

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20211104.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20211104_lab.xml EX-101.LAB 23970
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20211104_pre.xml EX-101.PRE 12644
9 EXTRACTED XBRL INSTANCE DOCUMENT advm-20211104_htm.xml XML 10551
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 211380067
SIC: 2836 Biological Products, (No Diagnostic Substances)